Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $255.39 and last traded at $254.5860, with a volume of 39971 shares traded. The stock had previously closed at $255.37.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
The firm has a market capitalization of $2.91 billion, a price-to-earnings ratio of 21.72 and a beta of 0.65. The business has a fifty day moving average price of $223.29 and a two-hundred day moving average price of $212.82.
Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund
A number of hedge funds have recently modified their holdings of FBT. Quad Cities Investment Group LLC grew its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 1.9% during the 2nd quarter. Quad Cities Investment Group LLC now owns 8,782 shares of the company’s stock worth $2,177,000 after purchasing an additional 166 shares during the period. Dynamic Advisor Solutions LLC grew its position in First Trust NYSE Arca Biotechnology Index Fund by 255.4% during the second quarter. Dynamic Advisor Solutions LLC now owns 4,247 shares of the company’s stock valued at $1,053,000 after buying an additional 3,052 shares during the period. Vigilare Wealth Management purchased a new position in First Trust NYSE Arca Biotechnology Index Fund in the second quarter valued at $219,000. Stonebridge Financial Group LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the second quarter worth about $328,000. Finally, Parallel Advisors LLC boosted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% during the 1st quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock worth $37,000 after acquiring an additional 169 shares in the last quarter.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Articles
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
